pGOLD Multiplexed Serology Assays
Infectious Diseases (e.g., Dengue, Zika, COVID-19)
Research/Development & Commercial (EUA for COVID-19)Active
Key Facts
Indication
Infectious Diseases (e.g., Dengue, Zika, COVID-19)
Phase
Research/Development & Commercial (EUA for COVID-19)
Status
Active
Company
About Nirmidas Biotech
Nirmidas Biotech is a privately-held diagnostics and imaging tools company leveraging its proprietary plasmonic gold (pGOLD) and near-infrared (NIR) technology platforms. Its product portfolio spans from high-accuracy, multiplexed serological assays (including an FDA EUA-authorized COVID-19 test) to advanced in vivo imaging systems for preclinical research. The company is strategically positioned at the intersection of research tools and clinical diagnostics, with affiliations to Janssen Labs, Stanford StartX, and MIT ILP providing validation and network advantages.
View full company profile